Related Experiment Video

Updated: Aug 7, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Tumor markers in testicular cancer

W J Catalona

    The Urologic Clinics of North America
    |October 1, 1979
    PubMed

    Abstract:

    The tumor markers alpha-fetoprotein and human chorionic gonadotropin have proved to be useful in staging disease in patients with testicular carcinomas. Moreover, their detection has often had a bearing on the therapeutic regimen selected. The nature and value of these tumor markers are discussed in detail, and other potentially useful oncofetal gene products are reviewed.

    More Related Videos

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    Related Experiment Videos

    Last Updated: Aug 7, 2026

    A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
    06:23

    A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

    Published on: January 12, 2017

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    Related Concept Videos

    Disorders of the Male Reproductive System01:20

    Disorders of the Male Reproductive System

    Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
    Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

    Articles linked to this work by shared authors, journal, and citation graph.

    Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?

    Prostate cancer and prostatic diseases·2016

    T rosette assay: in vitro correlate of cellular immunity.

    Urology·2011

    Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.

    Prostate cancer and prostatic diseases·2006

    TGFBR1*6A is not associated with prostate cancer in men of European ancestry.

    Prostate cancer and prostatic diseases·2004

    Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines.

    Medical oncology (Northwood, London, England)·2004

    Identification of a gene frequently mutated in prostate tumors.

    Medical oncology (Northwood, London, England)·2002

    Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

    The Urologic clinics of North America·2026

    Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

    The Urologic clinics of North America·2026

    Economic Considerations in the Management of Superficial Bladder Cancer.

    The Urologic clinics of North America·2026

    Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

    The Urologic clinics of North America·2026

    Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non-Muscle-Invasive Disease.

    The Urologic clinics of North America·2026

    Surveillance Protocols: Balancing Patient Burden and Cancer Control.

    The Urologic clinics of North America·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us